TCL Archive Preventive Ovarian Surgery Recommended For Women with BRCA1 Mutations by Age 35 February 28, 2014
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers May 29, 1981
